Company intelligence / Profile preview
Wanbangde Pharmaceutical Holding Group
Taizhou, Zhejiang, Chinaen.wanbang.com.cn ↗
- Ownership
- Private
- Employees
- ~1605
- Development stage
- Commercial
01
Overview
Wanbangde has a broad commercial portfolio focused on cardiovascular and cerebrovascular medicines and nervous system drugs. Its core products include ginkgo leaf dropping pills and huperzine A. Huperzine A has been approved for Alzheimer’s Disease in China since the mid‑1990s. The company also conducts clinical trials for new formulations such as injectable huperzine A. Recent clinical activity includes a completed Phase I study of huperzine A injection. The company also partners internationally for innovative drug development.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularNeurology
- Modalities
- Small moleculeBiologicNatural botanical medicineSynthetic peptide
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
D‑Pharm Israel—co-development of DP-b99 brain nerve cell protective agent for stroke/neuroprotection
Beyond the preview
Go deeper on Wanbangde Pharmaceutical Holding Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wanbangde Pharmaceutical Holding Group.